Abstract
BackgroundAccurate measurement of disease activity is important for optimal management of patients with rheumatoid arthritis (RA). Better understanding of similarities and differences among the available clinical and biomarker-based disease activity...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have